THE XENOBIOTIC DETOXIFICATION SYSTEM IN THE THERAPY OF THREATENED ABORTION


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Despite performed therapy for abortion, the highest risk of miscarriage was associated with a combination of the risky alleles of the ABCB1 and GSTP1 genes; the frequency of this combination was 13.2%.

全文:

受限制的访问

作者简介

O. Makarov

N.I. Pirogov Russian National Research Medical University

Professor

S. Lunina

N.I. Pirogov Russian National Research Medical University

Email: Svetlana.lunina2011@yandex.ru

L. Salnikova

N.I. Vavilov Institute of General Genetics, Russian Academy of Sciences

N. Lutsenko

N.I. Pirogov Russian National Research Medical University

V. Goncharova

N.I. Pirogov Russian National Research Medical University

参考

  1. Сальникова Л.Е., Замулаева И.А., Белопольская О.Б. и др. Встречаемость TCR-мутантных лимфоцитов у человека в зависимости от генотипов по локусам детоксикации ксенобиотиков // Экологическая генетика. - 2010; 8 (2): 18-23.
  2. Бочков Н.П. Клиническая генетика / М.: ГЭОТАР-Мед, 2002; 457 с.
  3. Bansal T., Jaggi M., Khar R. et al. Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy // J. Pharm. Pharmaceut. Sci. -2009; 12 (1): 46-78.
  4. Diergaarde B., Potter J., Jupe E. et al. Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer // Cancer Epidemiol. Biomarkers Prev. - 2008; 17 (7): 1751-9.
  5. Fertuck K., Matthews J., Zacharewski T. Hydroxylated benzo[a]pyrene metabolites are responsible for in vitro estrogen receptor-mediated gene expression induced by benzo[a]pyrene, but do not elicit uterotrophic effects in vivo // Toxicol. Sci. - 2001; 59 (2): 231-40.
  6. Hall M., Handley M., Gottesman M. Is resistance useless? Multidrug resistance and collateral sensitivity // Trends Pharmacol. Sci. - 2009; 30 (10): 546-56.
  7. Hamajima N. PCR-CTPP: a new genotyping technique in the era of genetic epidemiology // Exp. Rev. Mol. Diagn. - 2001; 1 (1): 119-23.
  8. Harbottle A., Daly A., Atherton K. et al. Role of glutathione S-transferase P1, P-glycoprotein and multidrug resistance-associated protein 1 in acquired doxorubicin resistance // Intern. J. Cancer. - 2001; 92 (6): 777-83.
  9. Josephy P. Genetic Variations in Human Glutathione Transferase Enzymes: Significance for Pharmacology and Toxicology // Human Genom. Prot. Vol. - 2010 (2010), Article ID 876940, 14 pages doi: 10.4061/2010/876940 URL: http://www. sage-hindawi.com/journals/hgp/2010/876940/
  10. Lamba J., Strom S., Venkataramanan R. et al. MDR1 genotype is associated with hepatic cytochrome P450 3A4 basal and induction phenotype // Clin. Pharmacol. Ther. - 2006; 79 (4): 325-38.
  11. Pasanen M. The expression and regulation of drug metabolism in human placenta // Adv. Drug Deliv. Rev. - 1999; 38: 81-97.
  12. Schilling C., Gallicchio L., Miller S. et al. Genetic polymorphisms, hormone levels, and hot flashes in midlife women // Maturitas. - 2007; 57 (2): 120-31.
  13. Shimada T., Watanabe J., Sutter T. et al. Catalytic properties of polymorphic human cytochrome P450 1B1 variants // Carcinogenesis. - 1999; 20 (8): 1607-13.
  14. Van Lieshout E., Knapen M., Lange W. Localization of glutathione S-transferases alpha and pi in human embryonic tissues at 8 weeks gestational age // Human Reprod. - 1998; 13 (5): 1380-6.
  15. Guengerich F. Cytochrome P 450s, drugs and diseases // Mol. Interv. -2003; 3 (4): 8-18.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Russkiy Vrach Publishing House, 2016